These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 26323466)

  • 21. Radioiodine 131I treatment for large nodular goiter: recombinant human thyrotropin allows the reduction of radioiodine 131I activity to be administered in patients with low uptake.
    Ceccarelli C; Antonangeli L; Brozzi F; Bianchi F; Tonacchera M; Santini P; Mazzeo S; Bencivelli W; Pinchera A; Vitti P
    Thyroid; 2011 Jul; 21(7):759-64. PubMed ID: 21568727
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant human thyrotropin before (131)I therapy in patients with nodular goitre: a meta-analysis of randomized controlled trials.
    Lee YY; Tam KW; Lin YM; Leu WJ; Chang JC; Hsiao CL; Hsu MT; Hsieh AT
    Clin Endocrinol (Oxf); 2015 Nov; 83(5):702-10. PubMed ID: 25370124
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Combination of Ultrasound-Guided Percutaneous Microwave Ablation and Radioiodine Therapy in Benign Thyroid Disease: A 3-Month Follow-Up Study.
    Korkusuz H; Happel C; Koch DA; Gruenwald F
    Rofo; 2016 Jan; 188(1):60-8. PubMed ID: 26566268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Does Iodine 131 treatment of goiter result in an acute increase of the volume and function of the thyroid gland?].
    Nygaard B; Faber JO; Hegedüs L
    Ugeskr Laeger; 1995 Dec; 157(50):7003-6. PubMed ID: 8545918
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radioiodine therapy for thyroid volume reduction of large goitres.
    Bachmann J; Kobe C; Bor S; Rahlff I; Dietlein M; Schicha H; Schmidt M
    Nucl Med Commun; 2009 Jun; 30(6):466-71. PubMed ID: 19381116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and efficacy of administering 0.2 mg of recombinant human TSH for two consecutive days as an adjuvant to therapy with low radioiodine doses in elderly out-patients with large nontoxic multinodular goiter.
    Giusti M; Cappi C; Santaniello B; Ceresola E; Augeri C; Lagasio C; Minuto F
    Minerva Endocrinol; 2006 Sep; 31(3):191-209. PubMed ID: 17213787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Radioiodine for nontoxic multinodular goiter.
    Huysmans D; Hermus A; Edelbroek M; Barentsz J; Corstens F; Kloppenborg P
    Thyroid; 1997 Apr; 7(2):235-9. PubMed ID: 9133693
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Radioiodine therapy in non-toxic multinodular goitre. The possibility of effect-amplification with recombinant human TSH (rhTSH).
    Bonnema SJ; Nielsen VE; Hegedüs L
    Acta Oncol; 2006; 45(8):1051-8. PubMed ID: 17118838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single, very low dose (0.03 mg) of recombinant human thyrotropin (rhTSH) effectively increases radioiodine uptake in the I-131 treatment of large nontoxic multinodular goiter.
    Mojsak MN; Abdelrazek S; Szumowski P; Rogowski F; Sykała M; Kostecki J; Kociura-Sawicka A; Jurgilewicz D; Myśliwiec J
    Nucl Med Rev Cent East Eur; 2016; 19(1):3-11. PubMed ID: 26841373
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radioiodine therapy in Graves' disease based on tissue-absorbed dose calculations: effect of pre-treatment thyroid volume on clinical outcome.
    Reinhardt MJ; Brink I; Joe AY; Von Mallek D; Ezziddin S; Palmedo H; Krause TM
    Eur J Nucl Med Mol Imaging; 2002 Sep; 29(9):1118-24. PubMed ID: 12192554
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Status of 3 years of hyperthyroidism treatment with iodine 131].
    Delgrange E; Weber E; Michel L; De Coster P; Buysschaert M; Donckier J
    Acta Clin Belg; 1994; 49(5):200-7. PubMed ID: 7992563
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Outpatient management of patients with large multinodular goitres treated with fractionated radioiodine.
    Howarth DM; Epstein MT; Thomas PA; Allen LW; Akerman R; Lan L
    Eur J Nucl Med; 1997 Dec; 24(12):1465-9. PubMed ID: 9391180
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Development of Basedow disease after radioiodine therapy for nodular goiter].
    Cseke B; Balázs C
    Orv Hetil; 2003 Nov; 144(47):2327-9. PubMed ID: 14725052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High prevalence of side effects after recombinant human thyrotropin-stimulated radioiodine treatment with 30 mCi in patients with multinodular goiter and subclinical/clinical hyperthyroidism.
    Romão R; Rubio IG; Tomimori EK; Camargo RY; Knobel M; Medeiros-Neto G
    Thyroid; 2009 Sep; 19(9):945-51. PubMed ID: 19678745
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Basedown disease, thyroid gland autonomy, nodular goiter. When is radiotherapy indicated?].
    Dietlein M; Schicha H
    MMW Fortschr Med; 2003 Apr; 145(17):47-9. PubMed ID: 12808806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long term efficacy of radioiodine treatment in hyperthyroidism.
    Bakos B; Takács I; Nagy Z; Kósa JP; Balla B; Tóbiás B; Halászlaki C; Szili B; Lakatos P
    Exp Clin Endocrinol Diabetes; 2013 Aug; 121(8):494-7. PubMed ID: 23934676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Different strategies to overcome the effect of carbimazole on high- and low-dose radioiodine therapy: results from continuous dose-effect models.
    Walter MA; Schindler C; Christ-Crain M; Müller-Brand J; Müller B
    Eur J Clin Invest; 2009 Jan; 39(1):51-7. PubMed ID: 19087129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utility of outpatient fractionated radioiodine therapy for Graves disease involving a large goiter measuring more than 100 mL in volume.
    Mizokami T; Hamada K; Maruta T; Higashi K; Tajiri J
    Endocr J; 2021 Sep; 68(9):1117-1125. PubMed ID: 33980774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radioiodine therapy in hyperthyroidism: inverse correlation of pretherapeutic iodine uptake level and post-therapeutic outcome.
    Walter MA; Christ-Crain M; Eckard B; Schindler C; Nitzsche EU; Müller-Brand J; Müller B
    Eur J Clin Invest; 2004 May; 34(5):365-70. PubMed ID: 15147334
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radioiodine therapy in voluminous multinodular non-toxic goitre.
    Verelst J; Bonnyns M; Glinoer D
    Acta Endocrinol (Copenh); 1990 Apr; 122(4):417-21. PubMed ID: 2333730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.